China Biotech Hopes Innovation Wins The Day As Legislative Attacks In US Congress Increase

 
• By Brian Yang

The latest development shows that BIOSECURE Act is gaining momentum in the US Congress and off Capitol Hill. In the meanwhile, the Chinese biotech sector embraces uncertainty but hopes that common interests in health innovation will prevail in the end.

China USA or United States trade and American tariffs conflict with two opposing trading partners as an economic import and exports dispute concept with 3D illustration elements
Chinese biotech stresses innovation, but is quiet on the looming conflict • Source: Shutterstock

More from Legislation

More from Pink Sheet